Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Only Orphans Cote LLC specializes in regulatory affairs consulting for orphan drug development. Led by Dr. Timothy Cote, former Director of the FDA Office of Orphan Products Development, the firm assists biotech and pharma companies with FDA/EMA orphan drug designations, IND submissions, expedited program applications, and overall regulatory strategy for rare disease products. The consultancy boasts a high success rate (>90%) in obtaining orphan designations for its clients and has supported over 120 new clients since its founding in 2021.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Only Orphans Cote LLC.